Trial Profile
Effect of atorvastatin on the metabolic syndrome of polycystic ovary syndrome.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Sep 2021
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Polycystic ovary syndrome
- Focus Therapeutic Use
- Acronyms PAT
- 18 Jun 2013 Results presented at the 95th Annual Meeting of the Endocrine Society.
- 05 Jun 2008 New trial record.